CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies
Clinical trial NCT05454241 · COMPLETED
Trial details
- NCT number
- NCT05454241
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2024-08-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.